$GEGR News : Announces Asset Exchange for Swiss Stem Cells Biotech SA (SSCB) and Re-You Suisse SA Gaensel Energy Group, Inc., (OTC Pink: GEGR) ("Gaensel" or the "Company"), a diversified holding company announces a corporate update.
As of March 1, 2022, the Company has agreed to terminate 100% of its interest in Swiss Stem Cells Biotech, SA, (SSCB). As of March 1, 2022, the Company has agreed to terminate 100% of its interest Re-You Suisse SA. The termination of these two interests was requested due to financial issues relating to US based ownership of Switzerland based companies. The Company, in consideration of these actions, has been authorized and empowered to establish Stem Cells Biotech in the United States which will have the exclusive rights in North and South America, including Canada. The Company, in consideration of these actions, has been authorized and empowered to establish Re-You SA the United States which will have the exclusive rights in North and South America, including Canada. The company will retain 50% of the ownership of the two United States including the technological and intellectual property.
The Company will be providing additional updates the week of March 7th , including our filing of our Annual Report and information on new corporate transactions.
About Gaensel Energy Group, Inc. (OTC Pink: GEGR):
Gaensel Energy Group asset base currently consists of proven companies in Biotech, Commodities, Health, Beauty - Fashion, Green and Renewable Energy, and Technology. The management teams for each of these divisions are actively seeking similar partners in each space for expansion and additional acquisitions. We have been listed on the United States OTC Markets since 2002 and the Company is current.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.